Large Biobank ProteoGenex maintains an extensive biorepository with over 200,000 biomaterials spanning oncology, neurology, immunology, infectious diseases, and more, offering rich opportunities for partner studies requiring well-characterized clinical samples and tissue-based research services.

Custom Research The company’s largest and fastest growing segment is exclusive, custom-design human tissue-based research services, presenting a clear cross-sell path to labs and biotechs seeking tailored specimen sourcing and pathology-informed analyses.

Global Footprint With headquarters in California and a large state-of-the-art lab in Moscow, ProteoGenex offers international collaboration potential, enabling access to diverse patient cohorts and regulatory-friendly cross-border research arrangements.

Regulatory Quality Specimens are collected under strict regulatory and ethical standards with extensive pathology data and clinical histories, enabling compliant data-rich studies and reducing vendor risk for customers in regulated research.

Growth Alignment Revenue in the modest range combined with a scalable biobank and growing service line suggests upsell opportunities to mid-market biotech firms and contract research organizations seeking high-quality biospecimen access and integrated research capabilities.